Antifungal Prophylaxis: Impact on Outcomes of Newly Diagnosed AML Patients Treated with a Hypomethylating Agent and Venetoclax
Year: 2021
Type: conference-abstract
Source: Blood
Institutions: Dana-Farber Cancer Institute, Brigham and Women's Hospital
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3213082892
